Efficiency and Cost Analysis of Cell Saver Auto Transfusion System in Total Knee Arthroplasty

Basit Öğe Kaydı
dc.authorid, mustafa/0000-0002-5301-6407
dc.contributor.authorBilgili, Mustafa Gokhan
dc.contributor.authorErcin, Ersin
dc.contributor.authorPeker, Gokhan
dc.contributor.authorKural, Cemal
dc.contributor.authorBasaran, Serdar Hakan
dc.contributor.authorDuramaz, Altug
dc.contributor.authorAvkan, Cevdet
dc.date.accessioned2024-09-29T16:09:40Z
dc.date.available2024-09-29T16:09:40Z
dc.date.issued2014
dc.departmentKarabük Üniversitesien_US
dc.description.abstractBackground: Blood loss and replacement is still a controversial issue in major orthopaedic surgery. Allogenic blood transfusion may cause legal problems and concerns regarding the transmission of transfusion-related diseases. Cellsaver Systems (CSS) were developed as an alternative to allogenic transfusion but CSS transfusion may cause coagulation, infection and haemodynamic instability. Aims: Our aim was to analyse the efficiency and cost analysis of a cell saver auto-transfusion system in the total knee arthroplasty procedure. Study Design: Retrospective comparative study. Methods: Those patients who were operated on by unilateral, cemented total knee arthroplasty (TKA) were retrospectively evaluated. Group 1 included 37 patients who were treated using the cell saver system, and Group 2 involved 39 patients who were treated by allogenic blood transfusion. The groups were compared in terms of preoperative haemoglobin and haematocrit levels, blood loss and transfusion amount, whether allogenic transfusion was made, degree of deformity, body mass index and cost. Results: No significant results could be obtained in the statistical comparisons made in terms of the demographic properties, deformity properties, preoperative laboratory values, transfusion amount and length of hospital stay of the groups. Average blood loss was calculated to be less in Group 1 (p<0.05) and cost was higher in Group 1 (p<0.05). Conclusion: Cell saver systems do not decrease the amount of allogenic blood transfusion and costs more. Therefore, the routine usage of the auto-transfusion systems is a controversial issue. Cell saver system usage does not affect allogenic blood transfusion incidence or allogenic blood transfusion volume. It was found that preoperative haemoglobin and body mass index rates may affect allogenic blood transfusion. Therefore, it is foreseen that auto-transfusion systems could be useful in patients with low haemoglobin level and body mass index.en_US
dc.identifier.doi10.5152/balkanmedj.2014.13267
dc.identifier.endpage153en_US
dc.identifier.issn2146-3123
dc.identifier.issn2146-3131
dc.identifier.issue2en_US
dc.identifier.pmid25207187en_US
dc.identifier.scopus2-s2.0-84901846987en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage149en_US
dc.identifier.urihttps://doi.org/10.5152/balkanmedj.2014.13267
dc.identifier.urihttps://hdl.handle.net/20.500.14619/7707
dc.identifier.volume31en_US
dc.identifier.wosWOS:000338061900008en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherGalenos Publ Houseen_US
dc.relation.ispartofBalkan Medical Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCell saver systemen_US
dc.subjectcosten_US
dc.subjecttotal knee arthroplastyen_US
dc.titleEfficiency and Cost Analysis of Cell Saver Auto Transfusion System in Total Knee Arthroplastyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu